BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2004
View Archived Issues
Eisai investigating novel AMPA receptor antagonists
Read More
Analgesic efficacy of tetrodotoxin in refractory cancer pain
Read More
Benefits of Permixon in patients with prostatic disorders
Read More
Analysis suggesting MC-1 effective in diabetic patients with hypertension supports MC-4232 program
Read More
Human growth hormone found effective against wasting in HIV patients receiving HAART
Read More
First double-blind evidence for efficacy of topical clonazepam in stomatodynia
Read More
Dual PPARalpha/gamma agonists under investigation for metabolic syndromes at Dr. Reddy
Read More
Novel potent inhibitors of palmitoyl-CoA oxidation
Read More
Update on novel antitumor drugs under development by Salmedix
Read More
Amgen returns epratuzumab rights to Immunomedics
Read More
Approval for new formulation of Protonix I.V.
Read More
Phase III MabThera trial meets primary endpoints two years early
Read More
Acambis suspends enrollment in ACAM-2000 phase III trials
Read More
Phase I protocol for ENT-103 being drawn up
Read More
New phase II trial evaluates elsamitrucin for refractory NHL
Read More
West Nile patient responds to GenoMed treatment
Read More
Sangart cleared to commence Swedish phase II trial of Hemospan
Read More
CS-917 completes second phase IIa trial
Read More
Phase II Pentrix trial set to commence
Read More
Cytos' second Immunodrug platform enters clinical development
Read More
Gabitril to enter phase III trial in second half of 2004
Read More
Expanded Provigil label approved in U.K.
Read More
Termination of Ono and Cortech's oral elastase inhibitor agreement
Read More
mGluR2 receptor agonists for neurological, psychiatric disorders claimed by Merck
Read More
Pfizer patents MMP-12 and MMP-13 inhibitors for treatment of respiratory diseases
Read More
C5a receptor modulators in early development at Neurogen
Read More
Orchid develops novel oxazolidinone derivatives useful as antibacterial agents
Read More
New biphenyl cannabinoids described in patent literature
Read More
Novel pyridyl substituted heterocycles for treatment, prevention of HCV
Read More
Patent claims method for treatment of osteoarthritis, rheumatoid arthritis, etc.
Read More